Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer (Q66030651)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
clinical trial
Language Label Description Also known as
English
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
clinical trial

    Statements

    title
    Phase III Study to Compare 6 Courses of FEC (Fluorouracil, Epirubicin and Cyclophosphamide) vs. 4 Courses of FEC Followed by 8 Weekly Paclitaxel Administrations, as Adjuvant Treatment for Node Positive Operable BC Patients (English)
    0 references
    country
    Spain
    0 references
    start time
    November 1999
    0 references
    end time
    December 2005
    0 references
    number of participants
    1,289
    0 references
    research intervention
    paclitaxel
    0 references
    (RS)-cyclophosphamide
    0 references
    fluorouracil
    0 references
    minimum age
    18 year
    0 references
    maximum age
    70 year
    0 references

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q66030651&oldid=2238093531"